Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...
HC Wainwright restated their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Free Report) in a report issued on Friday morning,Benzinga reports. They currently have a $2.50 target price on the ...
The Dr. Zachary Solomon Scholarship for Medical Students has been established to recognize and support the next generation of visionary healthcare professionals. With a focus on fostering medical ...